Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of RAYOS® Compared to Immediate-Release Prednisone to Improve Fatigue and Control Morning Symptoms in Subjects With Systemic Lupus Erythematosus

NCT03098823 is registered in ClinicalTrials.gov with Ampel BioSolutions, LLC as lead sponsor.

NCT NCT03098823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03098823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of RAYOS® Compared to Immediate-Release Prednisone to Improve Fatigue and Control Morning Symptoms in Subjects With Systemic Lupus Erythematosus
Lead sponsor
Ampel BioSolutions, LLC
Phase
Phase 4
Overall status
Completed
Start date
September 12, 2017
Completion date
June 15, 2020
Enrollment
62 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, lupus erythematosus, lupus erythematosus, systemic